
Inspires curiosity and a thirst for knowledge.
Andy Anglemyer is Research Associate Professor in the Department of Preventive and Social Medicine at the University of Otago. He earned an MPH in Epidemiology and Biostatistics from the University of California, Berkeley in 2006 and a PhD in Epidemiology from the same institution in 2010. As an Infectious Diseases Epidemiologist and Study Design Methodologist, Anglemyer has led data science initiatives on public health topics including disparities in public versus private health services in developing countries, risks of homicide and suicide associated with firearms, community-engaged interventions for U.S. school children, clinical outcomes for encephalitis, mental health services for chronic inebriates, early effects of HIV treatment, social network influences on high-risk behaviors, U.S. military retention, and operations research. His methodological expertise focuses on using disease surveillance data to identify health care gaps, alternative evaluations of the HIV care continuum, and meta-analytical techniques for small-sample animal models and reviews of reviews.
Anglemyer's research addresses infectious diseases epidemiology, study design methodology, firearms-related violence perpetration and self-harm, and pedagogy in statistics, data analytics, and study methodology. Notable publications include 'Large Reductions in Invasive Pneumococcal Disease and Related Morbidities Among Children in New Zealand After Change From PCV10 to PCV13' (2025, Journal of Infectious Diseases), 'Firearm-Related Hospitalization and Death in Aotearoa New Zealand' (2025, Annals of Internal Medicine), 'Digital Contact Tracing in Aotearoa New Zealand' (2025, New Zealand Medical Journal), and 'HPV Vaccination in Aotearoa New Zealand' (2025, Vaccine). His scholarship has amassed 5,173 citations with an h-index of 30. He previously taught statistics, linear regression, data analytics, survey methods, and study design. Anglemyer served on the WHO HIV Treatment Guidelines Committee (2009-2015) and currently contributes to the Cochrane Collaboration Methods Support Unit and as Epidemiology Editor for Cochrane Collaboration (both 2019-present).